Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia

被引：1
|
作者：
Sharma, T
Lieberman, JA
McEvoy, JP
Perkins, DO
Hamer, RM
Zipursky, RB
Kahn, RS
Gur, RE
Centorrino, F
Glick, I
Green, AI
Nemeroff, CB
Rothschild, AJ
Strakowski, SM
Tohen, M
Tollefson, GD
机构：
[1] Clin Neurosci Res Ctr, Res, Dartford, England
[2] Univ N Carolina, Sch Med, Mental Hlth & Neurosci Clin Res C, Chapel Hill, NC USA
[3] John Umstead Hosp, Butner, NC USA
[4] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA
[5] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[6] Univ Med Ctr, Dept Psychiat, Utrecht, Netherlands
[7] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA
[8] Harvard Univ, Sch Med, Bipolar & Psychot Disorders Clin, Belmont, MA 02178 USA
[9] Stanford Univ, Sci Stanford Univ Med Ctr, Stanford, CA 94305 USA
[10] Univ Hartford, Sch Med, Massachusetts Mental Hlth Ctr, Boston, MA USA
[11] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[12] Univ Massachusetts, Sch Med, Clin Res, Boston, MA 02125 USA
[13] Univ Cincinnati, Cincinnati, OH 45221 USA
[14] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)91655-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S134 / S135
页数：2
相关论文
共 50 条
  • [31] Diagnostic stability and long-term symptomatic and functional outcomes in first-episode antipsychotic-naive patients with schizophrenia
    Klaerke, Lea R.
    Baandrup, Lone
    Fagerlund, Birgitte
    Ebdrup, Bjorn H.
    Pantelis, Christos
    Glenthoj, Birte Y.
    Nielsen, Mette O.
    [J]. EUROPEAN PSYCHIATRY, 2019, 62 : 130 - 137
  • [32] Atypical antipsychotic medication 1N the treatment of first episode schizophrenia
    Sheitman, B
    Koreen, A
    Lee, H
    Mendelovvitz, A
    Alvir, J
    Lieberman, J
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 71 - 71
  • [33] Long-Term Treatment with Antithyroid Drugs: Efficacy and Safety
    Malboosbaf, Ramin
    Azizi, Fereidoun
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2020, 18
  • [34] Safety of the first long-acting atypical antipsychotic
    Llorca, PM
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S99 - S99
  • [35] Severity of core symptoms in first episode schizophrenia and long-term remission
    Marchesi, Carlo
    Affaticati, Andrea
    Monici, Alberto
    De Panfilis, Chiara
    Ossola, Paolo
    Tonna, Matteo
    [J]. PSYCHIATRY RESEARCH, 2015, 225 (1-2) : 129 - 132
  • [36] EUFEST: A randomized pragmatic long-term trial in first episode schizophrenia
    Kahn, R
    Boter, H
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S56 - S56
  • [37] Is Repetition Suppression Intact in Long-Term and First-Episode Schizophrenia?
    Andreaggi, Christian A.
    Coffman, Brian A.
    Haigh, Sarah M.
    Murphy, Timothy K.
    Ward, Kayla L.
    Salisbury, Dean F.
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 223S - 223S
  • [38] Long-term outcome of first-episode schizophrenia in an urban center
    Abdel-Baki, A
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 80 - 80
  • [39] Cognition, schizophrenia, and the atypical antipsychotic drugs
    Meltzer, HY
    Park, S
    Kessler, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) : 13591 - 13593
  • [40] Atypical antipsychotic drugs in the treatment of schizophrenia
    Meltzer, HY
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2001, 55 (02) : 86 - 86
12345